Bank of New York Mellon
BNR

Bank of New York Mellon’s Burning Rock Biotech BNR Stock Holding History

Bank of New York Mellon’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,617
Closed -$647K – 4621
2021
Q3 		$647K Buy
3,617
+86
+2% +$19.1K ﹤0.01% 3656
2021
Q2 		$1.04M Buy
+3,531
New +$1.04M ﹤0.01% 3392

Other funds holding BNR

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon's BNR Position: Q4 2021 in Review

Bank of New York Mellon sold out of Burning Rock Biotech (BNR) in Q4 2021, closing a stake of 3,617 shares — an estimated $647K sold.

Bank of New York Mellon first reported a position in BNR in Q2 2021 and held it in 2 quarters. The position peaked at $1.04M in Q2 2021. 62 funds tracked by Wall St. Rank hold BNR as of Q4 2021.

  • Bank of New York Mellon reported no remaining Burning Rock Biotech position as of Q4 2021 after selling out during the quarter.
  • Bank of New York Mellon sold 3,617 Burning Rock Biotech shares in Q4 2021, an estimated $647K.
  • Bank of New York Mellon first reported a position in Burning Rock Biotech in Q2 2021 and held it in 2 quarters.
  • Bank of New York Mellon's Burning Rock Biotech position peaked at $1.04M in Q2 2021.
  • 62 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q4 2021.

Based on Bank of New York Mellon's 13F filing for Q4 2021, filed 11 Feb 2022.